You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

advanced macular degeneration

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Age-Related Macular Degeneration Trial in Sydney, Melbourne, Tel Aviv (VOY-101)

Recruiting
  • Age-Related Macular Degeneration
  • VOY-101
  • Sydney, New South Wales, Australia
  • +3 more
Oct 17, 2023

Age-related Macular Degeneration, Geographic Atrophy Trial (VOY-101)

Recruiting
  • Age-related Macular Degeneration
  • Geographic Atrophy
  • VOY-101
  • Bellaire, Texas
    Retina Consultants of Texas
Nov 17, 2022

Geographic Atrophy Trial (BI 771716)

Not yet recruiting
  • Geographic Atrophy
  • BI 771716
  • (no location specified)
Aug 29, 2023

Age-related Macular Degeneration Trial in Israel, United States (OpRegen)

Completed
  • Age-Related Macular Degeneration
  • OpRegen
  • (no location specified)
Nov 1, 2022

Surgical Menopause Using Optical Coherence Tomography (OCT)

Completed
  • Corneal Deformity
  • +2 more
  • Optic coherence tomography
  • Batman, Turkey
    Batman education adn research hospital
Jun 17, 2023

Cataract, Macular Degeneration Advanced Trial (Cataract Surgery)

Withdrawn
  • Cataract
  • Macular Degeneration Advanced
  • Cataract Surgery
  • (no location specified)
Sep 27, 2021

Diabetic Macular Edema, Retinal Disease, Macular Edema Trial in United States (Aflibercept, foselutoclax)

Not yet recruiting
  • Diabetic Macular Edema
  • +8 more
  • Bakersfield, California
  • +7 more
Aug 23, 2023

Macular Degeneration Trial in United Kingdom, United States (BI 754132)

Terminated
  • Macular Degeneration
  • BI 754132
  • Beverly Hills, California
  • +12 more
Aug 23, 2022

Age-Related Maculopathy, Age-Related Maculopathies, Eye Diseases Trial in United States (RN6G, Placebo)

Completed
Has Results
  • Age-Related Maculopathy
  • +4 more
  • RN6G
  • Placebo
  • Campbell, California
  • +23 more
May 10, 2022

Age-Related Macular Degeneration, Geographic Atrophy Trial run by the NEI (Sirolimus)

Completed
Has Results
  • Age-Related Macular Degeneration
  • Geographic Atrophy
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 14, 2021

Exudative Age-related Macular Degeneration Trial in United States (RBM-007 Injectable Solution, Aflibercept, Sham)

Completed
  • Exudative Age-related Macular Degeneration
  • RBM-007 Injectable Solution
  • +2 more
  • Phoenix, Arizona
  • +7 more
Feb 5, 2022

Dry Age-related Macular Degeneration, Geographic Atrophy, Gene Therapy Trial (Intravitreal AAVCAGsCD59, Intravitreal Sham

Withdrawn
  • Dry Age-related Macular Degeneration
  • +3 more
  • Intravitreal AAVCAGsCD59
  • Intravitreal Sham Injection
  • (no location specified)
May 6, 2021

Neovascular Age-related Macular Degeneration Trial in United States (UBX1325, EYLEA® (aflibercept) Injection 2 mg (0.05mL))

Recruiting
  • Neovascular Age-related Macular Degeneration
  • UBX1325
  • EYLEA® (aflibercept) Injection 2 mg (0.05mL)
  • Beverly Hills, California
  • +24 more
May 19, 2022

Dry Age-related Macular Degeneration Trial in Boston (AAVCAGsCD59)

Completed
  • Dry Age-related Macular Degeneration
  • AAVCAGsCD59
  • Boston, Massachusetts
    Ophthalmic Consultants of Boston
Mar 30, 2021

Dry Age Related Macular Degeneration Trial in United States (MA09-hRPE)

Completed
  • Dry Age Related Macular Degeneration
  • MA09-hRPE
  • Los Angeles, California
  • +3 more
Jul 4, 2021

Age-Related Macular Degeneration Trial run by the NEI (iPSC-derived RPE/PGLA transplantation)

Recruiting
  • Age-Related Macular Degeneration
  • iPSC-derived RPE/PLGA transplantation
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 28, 2023

Age-related Macular Degeneration Trial in Coimbra (Blood draw and urine collection)

Completed
  • Age-related Macular Degeneration
  • Blood draw and urine collection
  • Coimbra, Portugal
    AIBILI
Jan 6, 2023

VeriSee AMD in Screening for Age-Related Macular Degeneration

Completed
  • Macular Degeneration, Age Related
  • Maculopathy, Age Related
    • Taipei, Taiwan
      National Taiwan University Hospital
    Oct 23, 2022

    Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Beijing (Intravitreal injection of IBI302(dose 1),

    Suspended
    • Neovascular Age-related Macular Degeneration
    • Diabetic Macular Edema
    • Intravitreal injection of IBI302(dose 1)
    • +3 more
    • Beijing, Beijing, China
      Peking University People's Hospital
    Jul 17, 2023

    Preparation of Patient Autologous Induced Pluripotent Stem

    Not yet recruiting
    • Age-Related Macular Degeneration
    • somatic cell collection
    • (no location specified)
    Aug 14, 2023

    Progression of Intermediate Age-Related Macular Degeneration

    Recruiting
    • Age-Related Macular Degeneration
    • No intervention
    • Encino, California
    • +4 more
    Aug 8, 2022

    Intestinal Microbiome in Wet Age-related Macular Degeneration

    Recruiting
    • Age-Related Macular Degeneration
    • Sample examination
    • Ioánnina, Epirus, Greece
    • +1 more
    Feb 23, 2023

    Neovascular Age-related Macular Degeneration Trial in Graz (Aflibercept 40 MG/ML, Faricimab 120 MG/ML)

    Recruiting
    • Neovascular Age-related Macular Degeneration
    • Aflibercept 40 MG/ML
    • Faricimab 120 MG/ML
    • Graz, Styria, Austria
      Department of Ophthalmolgy, Medical University Graz
    Jul 3, 2023

    Single Injection of Faricimab for nAMD With Persisting Fluid

    Active, not recruiting
    • Neovascular Age-related Macular Degeneration
    • Glostrup, Denmark
      Miklos Schneider
    Nov 3, 2023

    Neovascular Age-related Macular Degeneration Trial in Suzhou (Aflibercept Ophthalmic, IBI302)

    Not yet recruiting
    • Neovascular Age-related Macular Degeneration
    • Aflibercept Ophthalmic
    • IBI302
    • Suzhou, Jiangsu, China
      Innovent Biologics (Suzhou) Co,Ltd.
    Jul 25, 2023